More than 300 patients, including Rob Leighton of Westbrook, are participating in a new initiative that links them with clinical trials and other options, but it’s too early to say whether the effort has saved lives. “Hopefully the [tumors] continue to shrink and eventually go away,” Leighton said. “They’re really not sure what’s going to happen.”